发明授权
- 专利标题： CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD
- 专利标题（中）： 无菌可注射阿立哌唑的控释制剂和方法
-
申请号： EP04795514.1申请日： 2004-10-18
-
公开(公告)号： EP1675573B2公开(公告)日： 2012-06-13
- 发明人: KOSTANSKI, Janusz W. , MATSUDA, Takakuni Corpo Faburesu B-201 , NERURKAR, Manoj , NARINGREKAR, Vijay H.
- 申请人： OTSUKA PHARMACEUTICAL CO., LTD.
- 申请人地址： 2-9 Kanda Tsukasa-cho Chiyoda-ku Tokyo 101-8535 JP
- 专利权人： OTSUKA PHARMACEUTICAL CO., LTD.
- 当前专利权人： OTSUKA PHARMACEUTICAL CO., LTD.
- 当前专利权人地址： 2-9 Kanda Tsukasa-cho Chiyoda-ku Tokyo 101-8535 JP
- 代理机构： HOFFMANN EITLE
- 优先权： US513618P 20031023
- 国际公布： WO2005041937 20050512
- 主分类号： A61K9/19
- IPC分类号： A61K9/19 ; A61K47/38 ; A61K47/26 ; A61P25/18 ; A61K31/496
摘要：
A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.
公开/授权文献
信息查询
